Skip to content

Comparative Clinical Study of Ashtamangal Ghrita and Brahmi Ghrita in Management of Generalized Anxiety Disorder (Vishada)

A double blind randomized comparative clinical study to evaluate the efficacy of Ashtamangal Ghrita and Brahmi Ghrita in the management of generalized anxiety disorder (Vishada) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082407
Enrollment
60
Registered
2025-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

None listed

Sponsors

Nationnal Institute Of Ayurveda, Deemed to be university, Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex between the age of 20 60 years, Fulfilling DSM V diagnostic criteria for GAD and willing to participate in the study and having any sign and symptoms of Generalized Anxiety Disorder and Vishada will be included in the study.

Exclusion criteria

Exclusion criteria: Patients with symptoms of co-morbid psychiatric disorders, on psychotropic drugs, doing substance abuse like alcohol, tobacco , opium etc. and who having significant depression and other medical serious systemic diseases like cancer, tuberculosis etc and uncontrolled Hypertension, Diabetes Mellitus and dyslipidemia will be excluded in the study. Pregnant and lactating women will be excluded from the study. Having history of hypersensitivity or allergy to study drugs, Severe renal impairment (eGFR less than 30 mL/min/1.73 m ),Hepatic impairment (aspartate aminotransferase or alanine aminotransferase more than 2 times the upper limit of normal), Uncontrolled hypertension (systolic blood pressure more than 180 mmHg or diastolic blood pressure more than 100 mmHg)and Presence of any other serious medical condition that may interfere with study participation will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study will be the Change in Hamilton s anxiety rating scale.Timepoint: From Base line(0th day)to 28th day

Secondary

MeasureTime frame
Change in Pittsburgh Sleep Quality Index (PSQI) Change in Serum Cortisol level Change in symptoms of Vishada.Timepoint: From Base line(0th day)to 28th day

Countries

India

Contacts

Public ContactDr Neha Khandelwal

National Institute of Ayurveda , Deemed to be University , Jaipur , Rajasthan

bcpadhar@gmail.com9638435942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026